# Thin Basement Membrane Nephropathy > Thin basement membrane nephropathy for MBBS Pathology: diffuse GBM thinning below 250 nm, COL4A3/COL4A4, benign familial haematuria and its caveats. - Canonical URL: https://prepelephant.com/topics/mbbs/pathology/thin-basement-membrane - Exam / course: MBBS · Subject: Pathology - Publisher: PrepElephant (https://prepelephant.com) — Prepared and reviewed by the PrepElephant Academic Review Team - First published: 2026-10-02 - Last updated: 2026-10-02 - How to cite: "Thin Basement Membrane Nephropathy", PrepElephant, https://prepelephant.com/topics/mbbs/pathology/thin-basement-membrane ## Direct answer Diffuse thinning of the glomerular basement membrane (GBM) — below roughly 250 nanometres in adults on electron microscopy, against a normal 300 to 400 — defines thin basement membrane nephropathy, the condition behind "benign familial haematuria". It is usually autosomal dominant, caused by heterozygous COL4A3 or COL4A4 mutation, and may be the single commonest cause of persistent glomerular haematuria, present in up to about 1 per cent of the population. Patients have lifelong microscopic (occasionally episodic macroscopic) haematuria with normal blood pressure, normal renal function and no deafness or ocular signs; immunofluorescence is negative and light microscopy unremarkable. The modern caveat is that this sits at the mild end of the Alport spectrum, and a minority of carriers do progress. ## What you must remember - **The number:** GBM width below about 250 nanometres in adults (some laboratories use 200) on electron microscopy is the criterion; children need age-specific thresholds, since the normal GBM thickens with age. - **Genetics:** heterozygous COL4A3 or COL4A4, autosomal dominant; biallelic mutations in the same genes cause recessive Alport syndrome — one gene pair, a severity spectrum, the concept examiners now prefer. - **Clinical picture:** persistent glomerular (dysmorphic) erythrocytes from childhood, intermittent macroscopic haematuria with infections, normal blood pressure, normal creatinine and albumin, no extrarenal features. - **Diagnostic place:** biopsy is not usually required — the diagnosis is reached when isolated haematuria has a positive family history, normal function and negative immunofluorescence if biopsied; it is a diagnosis constructed by exclusion plus the electron-microscopic measurement. - **Rival to exclude:** IgA nephropathy is the other great cause of isolated glomerular haematuria in young Indian adults — episodic synpharyngitic macroscopic haematuria and mesangial IgA on immunofluorescence separate it. - **The caveat that earns marks:** a minority of heterozygous carriers — particularly those with a family history of end-stage renal disease — develop proteinuria, focal segmental glomerulosclerosis and slowly declining function; "benign" requires follow-up, not a discharge letter. - **Practical advice for patients:** annual blood pressure and creatinine, urine protein check, avoidance of nephrotoxic analgesic overuse; genetic counselling if both parents carry COL4A3/4 variants, since their offspring risk recessive Alport. ## Sorting isolated glomerular haematuria in clinic A 22-year-old sent for "urine abnormality" on an insurance medical tests the whole pathway. Step one: confirm the blood is glomerular — dysmorphic erythrocytes and erythrocyte casts on microscopy, not the uniform discs of lower-tract bleeding. Step two: ask the timing — haematuria within a day of a sore throat suggests IgA nephropathy; haematuria three to four weeks after a streptococcal infection suggests post-infectious glomerulonephritis; lifelong haematuria known since childhood with an affected parent points to basement-membrane disease. Step three: screen for the systemic — blood pressure, proteinuria (more than trace protein shifts the diagnosis away from thin basement membrane disease), creatinine, complement C3 where post-infectious disease is possible, and audiometry if any doubt about Alport exists. Step four is restraint. With isolated lifelong haematuria, normal function, negative protein and a compatible family history, most guidance now accepts a clinical diagnosis of thin basement membrane nephropathy; electron microscopy showing the uniformly thin GBM without splitting is the confirmatory image when biopsy is performed. The closing step is the safety net — review annually, because the patient crossing into proteinuria or rising creatinine has left the benign category and needs re-evaluation, possibly genetic testing for COL4A3/4. ## Where the exam sets its traps The examiner's favourite contrast is thin basement membrane disease versus Alport syndrome: the former has a uniformly thin GBM, no lamellation, no deafness, no lenticonus and no progression in the great majority; the latter (especially X-linked) shows the basket-weave splitting and extrarenal signs. But be ready for the synthesis question: the two are one spectrum, and an early X-linked Alport biopsy in a young boy can show thinning only — so a "thin membrane" report in a child with a suspicious family history is a red flag, not reassurance. Second trap: quoting "benign" without qualification; current teaching, reflected in Alport variant classifications, requires identifying the subset with COL4A3/4-associated risk before using the word. ## Frequently asked questions ### What GBM measurement defines thin basement membrane nephropathy? Diffuse thinning below approximately 250 nanometres in adults on electron microscopy, with age-adjusted thresholds in children. ### Which genes are implicated and how is it inherited? Heterozygous COL4A3 or COL4A4 mutations, usually autosomal dominant; the same genes biallelically cause recessive Alport syndrome, placing the two conditions on one spectrum. ### How is thin basement membrane disease distinguished from IgA nephropathy? Thin membrane disease lacks synpharyngitic macroscopic haematuria and shows negative immunofluorescence, whereas IgA nephropathy deposits mesangial IgA and often episodes coincide with infections. ### Does thin basement membrane nephropathy cause renal failure? For the large majority it does not, but a minority of COL4A3/4 carriers develop proteinuria and progressive chronic kidney disease, so annual follow-up is standard. ### When should a diagnosis of "benign familial haematuria" be questioned? When there is deafness, ocular findings, a family history of end-stage renal disease, significant proteinuria, or a child whose biopsy shows thinning — any of which demand Alport evaluation.